Clinical Trial Update: Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low-dose versus standard-dose rivaroxaban in elderly patients with atrial fibrillation; the study is currently recruiting to assess safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Atrial Fibrillation, Anticoagulant Adverse Reaction | Phase 4 | Status: RECRUITING